As of November 2024, Tissue Regenix Group has a market cap of $55.99M. This makes Tissue Regenix Group the world's 24568th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $58.22M | 20.19% |
2023 | $48.44M | 9103.54% |
2022 | $526.35K | 5.61% |
2021 | $498.40K | -0.93% |
2020 | $503.06K | -46.00% |
2019 | $931.59K | -84.62% |
2018 | $6.06M | -29.73% |
2017 | $8.62M | -54.88% |
2016 | $19.10M | 34.43% |
2015 | $14.21M | -24.69% |
2014 | $18.86M | -14.74% |
2013 | $22.13M | 86.27% |
2012 | $11.88M | -9.73% |
2011 | $13.16M | 20.21% |
2010 | $10.95M | 104.35% |
2009 | $5.36M | -61.67% |
2008 | $13.97M | -47.83% |
2007 | $26.78M | 15.00% |
2006 | $23.29M | - |